ICGORDMMO · Registering as Listener

International Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics 

10th Mar – 11th Mar 2027 Bali, Indonesia Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICGORDMMO
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

International Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics  conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 5 - Gender Equality SDG 10 - Reduced Inequalities

This track will explore the latest research and innovations in the diagnosis and treatment of gynecologic cancers. Emphasis will be placed on novel therapeutic approaches and their clinical implications.

This session will focus on the spectrum of reproductive disorders affecting women's health, including hormonal imbalances and infertility. Participants will discuss cutting-edge treatments and management strategies.

This track will address the complexities of maternal-fetal medicine, highlighting both common and rare complications during pregnancy. Experts will share insights on risk assessment and management protocols.

This session will delve into the latest surgical techniques and technologies in obstetrics, including minimally invasive procedures. The focus will be on improving maternal and neonatal outcomes.

This track will examine public health initiatives aimed at improving women's health across diverse populations. Discussions will include preventive measures, education, and policy implications.

This session will explore the psychological and social dimensions of gynecologic disorders, including their impact on quality of life. Participants will discuss strategies for integrated care and support.

This track will highlight recent advancements in fertility treatments and technologies, including assisted reproductive techniques. The implications for patient care and ethical considerations will also be discussed.

This session will focus on the latest research and treatment options for endometriosis, a prevalent yet often misunderstood condition. Experts will share insights on diagnosis, management, and patient education.

This track will cover various surgical techniques in gynecology, including laparoscopic and robotic-assisted surgeries. Outcomes and patient safety will be key focal points of discussion.

This session will address the disparities in health outcomes among women, focusing on socioeconomic, racial, and geographic factors. Strategies to mitigate these disparities will be explored.

This track will examine integrative health approaches in maternal care, including complementary therapies and holistic practices. The effectiveness and safety of these methods will be critically assessed.

COPYRIGHT © 2026 International Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics . ALL RIGHTS RESERVED